Controlling the quality of metabolomics data: new strategies to get the best out of the QC sample

Metabolomics

Volumn 11, Issue 3, 2015, Pages 518-528

  Godzien, Joanna ^a   Alonso Herranz, Vanesa ^a   Barbas, Coral ^a   Armitage, Emily Grace ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

False positives; In silico; QC surrogate; Quality assurance procedure; Quality control samples; Recursive analysis

Indexed keywords

EID: 84939883000     PISSN: 15733882     EISSN: 15733890     Source Type: Journal    
DOI: 10.1007/s11306-014-0712-4     Document Type: Article

References (13)

1. Ciborowski, M., Lipska, A., Godzien, J., Ferrarini, A., Korsak, J., Radziwon, P., et al. (2012a). Combination of LC–MS- and GC–MS-based metabolomics to study the effect of ozonated autohemotherapy on human blood. Journal of Proteome Research,11, 6231–6241. doi:10.1021/pr3008946.
2. Ciborowski, M., Teul, J., Martin-Ventura, J. L., Egido, J., & Barbas, C. (2012b). Metabolomics with LC–QTOF–MS permits the prediction of disease stage in aortic abdominal aneurysm based on plasma metabolic fingerprint. PLoS ONE,7, e31982. doi:10.1371/journal.pone.0031982.
3. Ciborowski, M., Ruperez, J., Martinez-Alcazar, M. P., Angulo, S., Radziwon, P., Olszanski, R., et al. (2010). Metabolomic approach with LC–MS reveals significant effect of pressure on diver’s plasma. Journal of Proteome Research,9, 4131–4137. doi:10.1021/pr100331j.
4. Dunn, W. B., Broadhurst, D., Begley, P., Zelena, E., Francis-McIntyre, S., Anderson, N., et al. (2011). Procedures for large-scale metabolic profiling of serum and plasma using gas chromatography and liquid chromatography coupled to mass spectrometry. Nature Protocols,6, 1060–1083. doi:10.1038/nprot.2011.335.
5. Gika, H. G., Theodoridis, G. A., Earll, M., & Wilson, I. D. (2012). A QC approach to the determination of day-to-day reproducibility and robustness of LC–MS methods for global metabolite profiling in metabonomics/metabolomics. Bioanalysis,4, 2239–2247. doi:10.4155/bio.12.212.
6. Gika, H. G., Theodoridis, G. A., Wingate, J. E., & Wilson, I. D. (2007). Within-day reproducibility of an HPLC–MS-based method for metabonomic analysis: Application to human urine. Journal of Proteome Research,6, 3291–3303. doi:10.1021/pr070183p.
7. Godzien, J., Ciborowski, M., Angulo, S., & Barbas, C. (2013a). From numbers to a biological sense: How the strategy chosen for metabolomics data treatment may affect final results. A practical example based on urine fingerprints obtained by LC–MS. Electrophoresis,34, 2812–2826. doi:10.1002/elps.201300053.
8. Godzien, J., Ciborowski, M., Whiley, L., Legido-Quigley, C., Ruperez, F. J., Barbas, C., et al. (2013b). In-vial dual extraction liquid chromatography coupled to mass spectrometry applied to streptozotocin-treated diabetic rats. Tips and pitfalls of the method. Journal of Chromatography A,1304, 52–60. doi:10.1016/j.chroma.2013.07.029.
9. Godzien, J., et al. (2010). Metabolomic approach with LC-QTOF to study the effect of a nutraceutical treatment on urine of diabetic rats. Journal of Proteome Research,10, 837–844. doi:10.1021/pr100993x.
10. Guy, P. A., Tavazzi, I., Bruce, S. J., Ramadan, Z., & Kochhar, S. (2008). Global metabolic profiling analysis on human urine by UPLC-TOFMS: Issues and method validation in nutritional metabolomics. Journal of Chromatography B,871, 253–260. doi:10.1016/j.jchromb.2008.04.034.
11. Kamleh, M. A., Ebbels, T. M. D., Spagou, K., Masson, P., & Want, E. J. (2012). Optimizing the use of quality control samples for signal drift correction in large-scale urine metabolic profiling studies. Analytical Chemistry,84, 2670–2677. doi:10.1021/ac202733q.
12. Llorach, R., Urpi-Sarda, M., Jauregui, O., Monagas, M., & Andres-Lacueva, C. (2009). An LC–MS-based metabolomics approach for exploring urinary metabolome modifications after cocoa consumption. Journal of Proteome Research,8, 5060–5068. doi:10.1021/pr900470a.
13. Sangster, T., Major, H., Plumb, R., Wilson, A. J., & Wilson, I. D. (2006). A pragmatic and readily implemented quality control strategy for HPLC–MS and GC–MS-based metabonomic analysis. Analyst,131, 1075–1078. doi:10.1039/b604498k.